Generation and characterization of CRISPR-Cas9-mediated XPC gene knockout in human skin cells

Ali Nasrallah1,2, Hamid-Reza Rezvani2,3, Farah Kobaisi1

  • 1Univ. Grenoble Alpes, CEA, Inserm, IRIG, UA13 BGE, Biomics, Grenoble, 38000, France.

Scientific Reports
|December 27, 2024
PubMed

Insights

Researchers created a new 3D skin model using Xeroderma pigmentosum group C (XPC) knockout cells. This model mimics XP-C disease, showing photosensitivity and impaired DNA repair, aiding in developing new therapies.

Area of Science:

  • Genetics and Molecular Biology
  • Dermatology
  • Cell Biology

Background:

  • Xeroderma pigmentosum group C (XPC) protein is essential for DNA damage repair via the global genome nucleotide excision repair (GG-NER) pathway.
  • UV radiation exposure causes DNA damage, and unrepaired damage due to XPC mutations significantly increases skin cancer risk.
  • Developing accurate models for studying XP-C disease and its associated skin cancers has been challenging.

Purpose of the Study:

  • To develop a novel in vitro model for Xeroderma pigmentosum group C (XP-C) disease.
  • To investigate the cellular and molecular phenotypes of XPC-deficient human skin cells.
  • To explore potential therapeutic strategies for XP-C disease and associated skin cancers.

Main Methods:

  • CRISPR-Cas9 gene editing was used to create XPC knockout human skin cells (keratinocytes, fibroblasts, melanocytes).
  • Phenotypic characterization included assessing photosensitivity, DNA repair capacity, and proliferative capacity.
  • A 3D reconstructed skin model was generated using XPC knockout cells to mimic the disease environment.

Main Results:

  • XPC knockout skin cells exhibited photosensitivity and impaired UV-induced DNA damage repair, recapitulating XP-C phenotypes.
  • These cells showed reduced proliferation and significant extracellular matrix remodeling in the 3D model.
  • Fibroblast secretome analysis revealed an augmented inflammatory response in XPC knockout cells.

Conclusions:

  • The developed 3D "disease on a dish" model accurately reflects XP-C disease characteristics.
  • This model offers valuable insights into XP-C molecular mechanisms and inflammatory shifts.
  • The approach can facilitate the development of novel preventive and therapeutic strategies for XP-C patients and skin cancer.